Myth: early stage investigators (ESIs) are more likely to receive NIH funding by pursuing a smaller award such as an R21 over an R01-equivalent. ❌
The data reinforce an important point for ESIs: a smaller or shorter award does not necessarily mean an easier award. Among those
00:00
